Skip to main content
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.15
-0.47 (-1.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Crinetics Pharmaceuticals Revenue

In the year 2025, Crinetics Pharmaceuticals had annual revenue of $7.70M with 640.71% growth. Crinetics Pharmaceuticals had revenue of $6.16M in the quarter ending December 31, 2025.

Revenue (ttm)
$7.70M
Revenue Growth
+640.71%
P/S Ratio
519.04
Revenue / Employee
$12,956
Employees
594
Market Cap
3.99B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.70M6.66M640.71%
Dec 31, 20241.04M-2.97M-74.11%
Dec 31, 20234.01M-724.00K-15.28%
Dec 31, 20224.74M3.66M339.42%
Dec 31, 20211.08M1.01M1,418.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ACADIA Pharmaceuticals 1.07B
Legend Biotech 1.03B
Telix Pharmaceuticals 803.79M
Amicus Therapeutics 634.21M
Catalyst Pharmaceuticals 588.99M
Travere Therapeutics 490.73M
Tango Therapeutics 62.38M
NewAmsterdam Pharma Company 22.50M
Revenue Rankings

CRNX News

More News